Industry must step up to tackle AMR threat

Generics manufacturers must “step up” to tackle antimicrobial resistance (AMR), the Access to Medicine Foundation has insisted, in a report that “systematically evaluates how a cross-section of the pharmaceutical industry is responding to the AMR threat”.